Voyager Therapeutics, Inc.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Accelerated filer
State of Incorporation
DE
Business Address
75 HAYDEN AVENUE, LEXINGTON, MA, 02421
Mailing Address
75 HAYDEN AVENUE, LEXINGTON, MA, 02421
Phone
857-259-5340
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2025
$132.33M
Net Income
$299.76M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | March 27, 2026 | View on SEC |
| 8-K Current report of material events | March 9, 2026 | View on SEC |
| 10-K Annual financial report | March 9, 2026 | View on SEC |
| 4 Insider stock transaction report | February 26, 2026 | View on SEC |
| 4 Insider stock transaction report | February 26, 2026 | View on SEC |
| 4 Insider stock transaction report | February 26, 2026 | View on SEC |
| 4 Insider stock transaction report | February 26, 2026 | View on SEC |
| 4 Insider stock transaction report | February 20, 2026 | View on SEC |
| 4 Insider stock transaction report | February 20, 2026 | View on SEC |
| 4 Insider stock transaction report | February 20, 2026 | View on SEC |
Annual Reports
10-K
March 9, 2026
- Proprietary TRACER™ capsid discovery platform offers a differentiated approach for gene therapies in neurological diseases.
- Strategic partnerships with Novartis, Neurocrine, and Alexion provide significant non-dilutive funding and validate technology, with Novartis collaboration having a total potential value exceeding $1.5 billion.
Insider Trading
SELL
4 insiders
10 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2836)
Kodiak Sciences Inc.
KOD
Biological Products, (No Diagnostic Substances)
BioAtla, Inc.
BCAB
Biological Products, (No Diagnostic Substances)
Cardiff Oncology, Inc.
CRDF
Biological Products, (No Diagnostic Substances)
HALOZYME THERAPEUTICS, INC.
HALO
Biological Products, (No Diagnostic Substances)
Adaptive Biotechnologies Corp
ADPT
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.